Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Platelet antiaggregatory prostaglandins reported by Taisho

April 5, 1996

E. Merck claims Na+/H+-exchange inhibitors

April 5, 1996

Na+/H+-exchange inhibitors reported by Hoechst

April 5, 1996

New antiarrhythmics from Nisshin Flour Milling

April 5, 1996

Cypros synthesizes adenosine deaminase inhibitors

April 5, 1996

New potassium channel openers from Nippon Kayaku

April 5, 1996

Suntory reports antiallergy agents

April 5, 1996

More new antiallergics from Japan Energy

April 5, 1996

New antiallergics from Japan Energy

April 5, 1996

Eisai claims cerebral antiischemic

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 17, 2025.
Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM
BioWorld
The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.